Delivery Order SPE2DB22D2214-SPE2DB25FS6RX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, issued on August 26, 2025, with completion targeted for August 27, 2025, carries firm fixed price terms and involves no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order represents a competitive award under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,546.29 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,701.51 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. This contract is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on September 5, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $27,153.26 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract, effective August 5, 2025, with a completion date of August 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,543.82 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a medication used to treat type 2 diabetes. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $8,294.09 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a ceiling value of $10,411.20 and an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract value of $11,992.10 and completion date of March 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, with a ceiling value of $1,091.46. This competitive, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. No set-aside designation was applied to this...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6RXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes management medication, under a firm fixed-price contract valued at $4,514.50. The order, placed on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location, serving the federal government's pharmaceutical supply needs for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The DLA's Medical Supply Chain relies on AmerisourceBergen Drug Corp as a critical vendor to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/25/25 |